Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
University of Illinois at Chi
Search grants from University of Illinois at Chi
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
The Electricidal Effect, a Novel Anti-Biofilm Strategy
Gene Expression of Retinal Ganglion Cells
Experimental Pathogenesis & Therapy of Ocular Adenovirus
Oxygen Free Radicals in Carcinogenesis
Recently added grants:
3D genome architecture and the origins of recurrent genomic rearrangements in prostate cancer
Role for TbetaRIII Shedding in the Tumor Microenvironment
Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis
Project 3: Long Non-Coding RNAs and Cancer
Improving urine drug test utility to mitigate prescription opioid risk
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN985081-003
Application #
7191436
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Illinois at Chi
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
NIH 2004
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261985081
/ University of Illinois at Chi
Comments
Be the first to comment on this grant